94 related articles for article (PubMed ID: 23128247)
1. Matrix metalloproteinase-9 gene polymorphisms and chronic kidney disease.
Okada R; Kawai S; Naito M; Hishida A; Hamajima N; Shinchi K; Chowdhury Turin T; Suzuki S; Mantjoro EM; Toyomura K; Arisawa K; Kuriyama N; Hosono S; Mikami H; Kubo M; Tanaka H; Wakai K;
Am J Nephrol; 2012; 36(5):444-50. PubMed ID: 23128247
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.
Saracini C; Bolli P; Sticchi E; Pratesi G; Pulli R; Sofi F; Pratesi C; Gensini GF; Abbate R; Giusti B
J Vasc Surg; 2012 Jan; 55(1):171-179.e2. PubMed ID: 22094117
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population.
Awakura Y; Ito N; Nakamura E; Takahashi T; Kotani H; Mikami Y; Manabe T; Kamoto T; Habuchi T; Ogawa O
Cancer Lett; 2006 Sep; 241(1):59-63. PubMed ID: 16466849
[TBL] [Abstract][Full Text] [Related]
4. Functional matrix metalloproteinase (MMP)-9 genetic variants modify the effects of hemodialysis on circulating MMP-9 levels.
Marson BP; Lacchini R; Belo V; Mattos SG; da Costa BP; Poli-de-Figueiredo CE; Tanus-Santos JE
Clin Chim Acta; 2012 Dec; 414():46-51. PubMed ID: 23010359
[TBL] [Abstract][Full Text] [Related]
5. Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease.
Horne BD; Camp NJ; Carlquist JF; Muhlestein JB; Kolek MJ; Nicholas ZP; Anderson JL
Am Heart J; 2007 Oct; 154(4):751-8. PubMed ID: 17893005
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
[TBL] [Abstract][Full Text] [Related]
7. [Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2) and MMP-9 genes with risk of gastric cancer in a Chinese population].
Zhang XM; Miao XP; Xiong P; Yu CY; Tan W; Qu SN; Sun T; Zhou YF; Lin DX
Ai Zheng; 2004 Nov; 23(11):1233-7. PubMed ID: 15522165
[TBL] [Abstract][Full Text] [Related]
8. Association of the MMP9 gene with childhood cedar pollen sensitization and pollinosis.
Inoue H; Mashimo Y; Funamizu M; Yonekura S; Horiguchi S; Shimojo N; Kohno Y; Okamoto Y; Hata A; Suzuki Y
J Hum Genet; 2012 Mar; 57(3):176-83. PubMed ID: 22237587
[TBL] [Abstract][Full Text] [Related]
9. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y
Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328
[TBL] [Abstract][Full Text] [Related]
10. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
Okamoto K; Mimura K; Murawaki Y; Yuasa I
J Gastroenterol Hepatol; 2005 Jul; 20(7):1102-8. PubMed ID: 15955221
[TBL] [Abstract][Full Text] [Related]
11. Assessment of matrix Gla protein, Klotho gene polymorphisms, and oxidative stress in chronic kidney disease.
Karsli Ceppioğlu S; Yurdun T; Canbakan M
Ren Fail; 2011; 33(9):866-74. PubMed ID: 21859400
[TBL] [Abstract][Full Text] [Related]
12. Gene polymorphisms of matrix metalloproteinase-2, -9 and -12 in periodontal health and severe chronic periodontitis.
Gürkan A; Emingil G; Saygan BH; Atilla G; Cinarcik S; Köse T; Berdeli A
Arch Oral Biol; 2008 Apr; 53(4):337-45. PubMed ID: 18155181
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype.
Grieu F; Li WQ; Iacopetta B
Breast Cancer Res Treat; 2004 Dec; 88(3):197-204. PubMed ID: 15609121
[TBL] [Abstract][Full Text] [Related]
14. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H
J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease.
Marson BP; Lacchini R; Belo V; Dickel S; da Costa BP; Poli de Figueiredo CE; Tanus-Santos JE
Am J Nephrol; 2012; 35(3):209-15. PubMed ID: 22302011
[TBL] [Abstract][Full Text] [Related]
16. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the MMP-9 (C-1562 T) and TIMP-2 (G-418C) gene promoter polymorphisms in patients with chronic periodontitis.
de Souza AP; Trevilatto PC; Scarel-Caminaga RM; de Brito RB; Barros SP; Line SR
J Clin Periodontol; 2005 Feb; 32(2):207-11. PubMed ID: 15691353
[TBL] [Abstract][Full Text] [Related]
18. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
19. A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women.
Lose F; Thompson PJ; Duffy D; Stewart GA; Kedda MA
Thorax; 2005 Aug; 60(8):623-8. PubMed ID: 16061701
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and risk factors for CKD in spouses and relatives of hemodialysis patients.
Tsai JC; Chen SC; Hwang SJ; Chang JM; Lin MY; Chen HC
Am J Kidney Dis; 2010 May; 55(5):856-66. PubMed ID: 20153917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
